Differential responses of myogenic C2C12 cells to hypoxia between growth and muscle-induction phases: Growth, differentiation and motility

Journal of Physical Therapy Science

Volumn 23, Issue 1, 2011, Pages 161-169

  Sato, Kaori ^b   Saida, Kosuke ^a   Yanagawa, Takashi ^b   Fukuda, Toshio ^a,b   Shirakura, Kenji ^b   Shinozaki, Hiromitsu ^a,b   Watanabe, Hideomi ^a,b  

^a GUNMA UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

C2C12; Hypoxia; Myogenesis

Indexed keywords

EID: 79955782228     PISSN: 09155287     EISSN: None     Source Type: Journal    
DOI: 10.1589/jpts.23.161     Document Type: Article

References (51)

1. Charge SB, Rudnicki MA: Cellular and molecular regulation of muscle regeneration. Physiological Society, 2004, 84: 209-238.
2. Hoppeler H, Vogt M, Weibel ER, et al.: Response of skeletal muscle mitochondria to hypoxia. Exp Physiol, 2003, 88: 109-119.
3. Kakarada Y, Takazawa H, Sato Y, et al.: Effects of resistance exercise combined with moderate vascular occlusion on muscular function in humans. J Appl Physiol, 2000, 88: 2097-2106.
4. Csete M: Oxygen in the Cultivation of Stem Cells. Ann N Y Acad Sci, 2005, 1049: 1-8.
5. Malladi P, Xu Y, Chiou M, et al.: Effect of reduced oxygen tension on chondrogenesis and osteogenesis in adipose-derived mesenchymal cells. Am J Physiol Cell Physiol, 2006, 290: 1139-1146.
6. Studer L, Csete M, Lee Sh, et al.: Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen. J Neurosci, 2000, 20: 7377-7383.
7. Greenbaum AR, Etherington PJE, Manek S, et al.: Measurements of oxygenation and perfusion in skeletal muscle using multiple microelectrodes. J Muscle Res Cell Motil, 1997, 18: 149-159.
8. 2. J Appl Physiol, 1998, 85: 627-634.
9. Di Carlo AD, Mori RD, Martelli F, at al.: Hypoxia inhibits myogenic differentiation through acceletrated MyoD degradation. J Biol Chem, 2004, 16: 16332-16338.
10. Grayson WL, Zhao F, Bunnell B, et al.: Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells. Biochem Biophys Res Commun, 2007, 358: 948-953.
11. Soeda A, Park M, Lee D, et al.: Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α. Oncogene, 2009, 28: 3949-3959.
12. Irisarri M, Lavista-Llanos S, Romero NM, et al.: Central role of the oxygendependent degradation domain of drosophila HIF-1α/Sima in oxygendependent nuclear export. Mol Biol Cell, 2009, 20: 3878-3887.
13. Li X, Zhu L, Chen X, et al.: Effects of hypoxia on proliferation and differentiation of myoblasts. Medical Hypotheses, 2007, 69: 629-636.
14. Mounier R, Pialoux V, Schmitt L, et al.: Effects of acute hypoxia tests on blood markers in high-level endurance athletes. Eur J Appl Physiol, 2009, 106: 713-720.
15. Sabourin LA and Rudnicki MA.: The molecular reguration of myogenesis. Clin Genet, 2000, 57: 16-25.
16. Olson EN, Klein WH: bHLH factors in muscle development: dead lines and commitments, what to leave in and to leave out. Genes Dev, 1994, 8: 1-8.
17. Lassar AB, Skapek SX, Novitch B: Curr Opin: Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. Cell Biol, 1994, 6: 788-794.
18. Schneider JW, Gu W, Zhu L, et al.: Reversal of terminal differentiation mediated by p107 in Rb-/-muscle cells. Science, 1994, 264: 1467-1471.
19. Walsh, KP.: Coordinate regulation of cell cycle and apoptosis during myogenesis. Cell Cycle Res, 1997, 3: 53-58.
20. Halevy O, Novitch BG, Spicer DB, et al.: Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science, 1995, 267: 1018-1021.
21. Zhu LL, Wu LY, Yew DT, et al.: Effects of hypoxia on the proliferation and differation of NSCs. Mol Neurobiol, 2005, 31: 231-242.
22. Zhao T, Zhang CP, Liu ZH, at al.: Hypoxia-driven proliferation of embryonic neural stem/progenitor cells-role of hypoxia-inducible transcription factor-1α. FEBS Journal, 2008, 275: 1824-1834.
23. 2 homeostasis by hypoxia-inducible factor1. Annu Rev Cell Dev Biol, 1999, 15: 551-578.
24. Chi JT, Wang Z, Nuyten DSA, et al.: Gene expression programs in response to hypoxia: Cell type specificity and prognostic significance in human cancers. PLoS Med, 2006, 3: e47: 395-409.
25. Yun Z, Lin Q, Giaccia AJ.: Adaptive myogenesis under hypoxia. Mol Cel Biol, 2005, 25: 3040-3055.
26. Ono Y, Sensui H, Sakamoto Y, et al.: Knockdown of hypoxia-inducible factor-1αby siRNA inhibits C2C12 myoblast differentiation. J Cell Bioc, 2006, 98: 642-649.
27. Trinkaus JP, Poste G, Nicolson GL: On the mechanism of metazoan cell movement. The Cell Surface in Animal Embryogenesis and Development: AmsterdamElsevier/North-Holland Biomedical.1976, pp.225-239.
28. Bonavaud S, Agbulut O, D'Honneur G, et al.: Preparation of isolated human muscle fibers: a technical report. In Vitro Cell Dev Biol-Animal, 2002, 38: 66-72.
29. Niizeki H, Kobayashi M, Horiuchi I, et al.: Hypoxia enhances the expression of autocrine motility factor and the motility of human pancreatic cancer cells. Br J Cancer, 2002, 86: 1914-1919
30. Nabi IR, Watanabe H, Raz A: Identification of B16-F1 melanoma autocrine motility-like factor receptor. Cancer Res, 1990, 50: 409-414.
31. Watanabe H, Carmi P, Hogan V, et al.: Purification of human tumor cell autocrine motility factor and molecular cloning of its receptor. J Biol Chem, 1991, 266: 13442-13448.
32. Jiang WG, Raz A, Jones AD, et al.: Expression of autocrine motility factor (AMF) and its receptor, AMFR, in human breast cancer. J Histochem Cytochem, 2006, 54: 231-241.
33. Yanagawa T, Funasaka T, Tsutsumi S, et al.: Novel roles of the autocrine motility factor/phosphoglucose isomerase in tumor malignancy. Endocr Relat Cancer, 2004, 11: 749-759.
34. Watanabe H, Takehara K, Date M. et al.: Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide. Cancer Res, 1996, 56: 2960-2963.
35. Paglia DE, Holland P, Baughan MA, et al.: Occurrence of detective hexosephosphate isomerization in human erythrocytes and leukocytes. N Engl J Med, 1969, 280: 66-71.
36. Niinaka Y, Paku S, Haga A, et al.: Expression and secretion of neuroleukin/ phosphosphate isomerase/maturation factor as autocrine motility factor by tumor cells. Cancer Res, 1998, 58: 2667-2674.
37. Yaffe D, Saxel O.: Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature, 1977, 270: 725-727.
38. Tada H, Shiho O, Kuroshima K, et al.: An improved colorimetric assay for interleukin 2. J Immunol Methods, 1986, 93: 157-165.
39. Yanagawa T, Watanabe H, Takeuchi T, et al.: Overexpression of autocrine motolity factor in metastatic tumor cells: possible association with augmented expression of KIF3A and GDI-β. Lab Invest, 2004, 84: 513-522.
40. Akimoto T, Ushida T, Miyaki S, et al.: Mechanical stretch is a downregulatory signal for differentiation of C2C12 myogenic cells. Materials Science and Engineering C, 2001, 17: 75-78.
41. Allen RA, Temm-Grove CJ, Sheehan SM, et al.: Skeletal muscle satellite cell cultures. Methods Cell Biol, 1998, 52: 155-176.
42. Krtolica A, Krucher NA, Ludlow JW.: Hypoxia-induced pRB hypophosphorylation results from downregulation of CDK and upregulation of PP1 activities. Oncogene, 1998, 17: 2295-2304.
43. Gardner LB, Li Q, Park MS, et al.: Hypoxia Inhibits G/S Transition through Regulation of p27 Expression. J Biol Chem, 2001, 276: 7919-7926.
44. Goda N, Ryan HE, Khadivi B, et al.: Hypoxia-Inducible Factor 1αis essential for cell cycle arrest during hypoxia. Mol Cell Biol, 2003, 23: 359-369.
45. Young SD, Marshall RS, Hill RP.: Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc Natl Acad Sci USA, 1988, 85: 9533-9537.
46. Zhong H, De Marzo AM, Laughner E, et al.: Overexpression of hypoxiainducible factor 1αin common human cancers and their metastases. Cancer Res, 1999, 59: 5830-5835.
47. Melillo G: Inhibiting hypoxia-inducible factor 1 for cancer therapy. Mol Cancer Res, 2006, 4: 601-605.
48. Kizaka-Kondoh S, Inoue M, Harada H, et al.: Tumor hypoxia; A target for selective cancer therapy. Cancer Sci, 2003, 4: 1021-1028.
49. Mayer A, Hockel M, Wree A, et al.: Lack of hypoxic response in uterine leiomyomas despite severe tissue hypoxia. Cancer Res, 2008, 68: 4719-4726.
50. Goto K, Okuyama R, Sugiyama H, et al.: Effects of heat stress and mechanical stretch of protein expression in cultured skeletal muscle cells. Eur J Physiol, 2003, 47: 247-253.
51. Tsutsumi S, Yanagawa T, Shimura T, et al.: Autocrine motility factor signaling enhance pancreatic cancer metastasis. Clin Cancer Res, 2004, 10: 7775-7784.